• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金淋巴瘤中CC趋化因子受体4阳性调节性T细胞的特异性募集促进了免疫豁免。

Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.

作者信息

Ishida Takashi, Ishii Toshihiko, Inagaki Atsushi, Yano Hiroki, Komatsu Hirokazu, Iida Shinsuke, Inagaki Hiroshi, Ueda Ryuzo

机构信息

Department of Internal Medicine and Molecular Science and Clinical Pathology, Nagoya City University Graduate School of Medical Sciences, Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya-shi, Aichi, Japan.

出版信息

Cancer Res. 2006 Jun 1;66(11):5716-22. doi: 10.1158/0008-5472.CAN-06-0261.

DOI:10.1158/0008-5472.CAN-06-0261
PMID:16740709
Abstract

Hodgkin lymphoma (HL) is characterized by the presence of a small number of tumor cells in a rich background of inflammatory cells, but the contribution of the abundant nontumor cells to HL pathogenesis is poorly understood. We showed that migratory CD4(+) cells induced by HL cells were hyporesponsive to T-cell receptor stimulation and suppressed the activation/proliferation of the effector CD4(+) T cells in an autologous setting. We further showed that HL cells in the affected lymph nodes were surrounded by a large number of lymphocytes expressing both CC chemokine receptor 4 (CCR4) and FOXP3. These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system. In addition, we showed that a chimeric anti-CCR4 monoclonal antibody (mAb) could deplete CCR4(+) T cells and inhibit the migration of CD4(+)CD25(+) T cells in vitro. Recognition of the importance of CCR4(+) Treg cells in the pathogenesis of HL will allow rational design of more effective treatments, such as use of an anti-CCR4 mAb, to overcome the suppressive effect of CCR4(+) Treg cells on the host immune response to tumor cells.

摘要

霍奇金淋巴瘤(HL)的特征是在丰富的炎症细胞背景中存在少量肿瘤细胞,但大量非肿瘤细胞对HL发病机制的作用却知之甚少。我们发现,HL细胞诱导的迁移性CD4(+)细胞对T细胞受体刺激反应低下,并在自体环境中抑制效应性CD4(+) T细胞的活化/增殖。我们进一步发现,受累淋巴结中的HL细胞被大量同时表达CC趋化因子受体4(CCR4)和FOXP3的淋巴细胞所包围。这些发现表明,HL细胞诱导的迁移性细胞发挥调节性T(Treg)细胞的功能,从而为肿瘤细胞营造一个有利于其逃避宿主免疫系统的环境。此外,我们还表明,一种嵌合抗CCR4单克隆抗体(mAb)能够在体外清除CCR4(+) T细胞并抑制CD4(+)CD25(+) T细胞的迁移。认识到CCR4(+) Treg细胞在HL发病机制中的重要性,将有助于合理设计更有效的治疗方法,如使用抗CCR4 mAb,以克服CCR4(+) Treg细胞对宿主针对肿瘤细胞的免疫反应的抑制作用。

相似文献

1
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.霍奇金淋巴瘤中CC趋化因子受体4阳性调节性T细胞的特异性募集促进了免疫豁免。
Cancer Res. 2006 Jun 1;66(11):5716-22. doi: 10.1158/0008-5472.CAN-06-0261.
2
Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma.人类慢性幽门螺杆菌感染和胃腺癌中黏膜调节性T细胞的功能与募集
Clin Immunol. 2006 Dec;121(3):358-68. doi: 10.1016/j.clim.2006.07.002. Epub 2006 Aug 23.
3
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.CC趋化因子受体4作为成人T细胞白血病/淋巴瘤免疫治疗的新型特异性分子靶点。
Clin Cancer Res. 2004 Nov 15;10(22):7529-39. doi: 10.1158/1078-0432.CCR-04-0983.
4
Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.CCR4⁺ 成人 T 细胞白血病细胞产生胸腺和激活调节趋化因子以及巨噬细胞衍生趋化因子。
Clin Cancer Res. 2005 Mar 15;11(6):2427-35. doi: 10.1158/1078-0432.CCR-04-0491.
5
Immunopathogenesis of lymphoma: focus on CCR4.淋巴瘤的免疫发病机制:聚焦于 CCR4。
Cancer Sci. 2011 Jan;102(1):44-50. doi: 10.1111/j.1349-7006.2010.01767.x. Epub 2010 Nov 2.
6
Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.人类外周血CD4+CD25+抑制性T细胞上皮肤与肠道偏向性归巢受体表达及内在CCR4表达
Eur J Immunol. 2003 Jun;33(6):1488-96. doi: 10.1002/eji.200323658.
7
CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells.皮肤利什曼病患者皮肤损伤中的CD4+CD25+ T细胞表现出天然调节性T细胞的表型和功能特征。
J Infect Dis. 2006 May 1;193(9):1313-22. doi: 10.1086/502980. Epub 2006 Mar 17.
8
Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.胸腺与激活调节趋化因子及其受体CCR4在淋巴结和皮肤间变性大细胞淋巴瘤及霍奇金病中的差异表达
Mod Pathol. 2002 Aug;15(8):838-44. doi: 10.1097/01.MP.0000021006.53593.B0.
9
Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.系统性红斑狼疮中CD4+CD25+调节性T细胞的频率和迁移能力改变
Rheumatology (Oxford). 2008 Jun;47(6):789-94. doi: 10.1093/rheumatology/ken108. Epub 2008 Apr 3.
10
Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.CCR4表达在成人T细胞白血病/淋巴瘤中的临床意义:其与皮肤受累及不良预后密切相关。
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3625-34.

引用本文的文献

1
Extracellular Vesicle miR-122-5p as a Prognostic Biomarker in Pediatric Classical Hodgkin Lymphoma.细胞外囊泡miR-122-5p作为儿童经典型霍奇金淋巴瘤的预后生物标志物
Int J Mol Sci. 2024 Dec 10;25(24):13243. doi: 10.3390/ijms252413243.
2
The Abundance of FOXP3, FOXP3/CD4 and CD8 Cells in the Microenvironment of Nodular Sclerosis and Mixed Cellularity Subtypes Is Associated with the Epstein-Barr Virus Status of Classic Hodgkin Lymphoma.结节硬化型和混合细胞型经典霍奇金淋巴瘤微环境中FOXP3、FOXP3/CD4及CD8细胞的丰度与爱泼斯坦-巴尔病毒状态相关。
Biomedicines. 2024 Jul 27;12(8):1680. doi: 10.3390/biomedicines12081680.
3
LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma.
仅含LIM结构域7:胰腺导管腺癌中通过调节性T细胞分化和趋化作用实现免疫逃逸的新型驱动因子
Cell Death Differ. 2025 Feb;32(2):271-290. doi: 10.1038/s41418-024-01358-7. Epub 2024 Aug 14.
4
Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer.非小细胞肺癌的肿瘤微环境特征及新型免疫治疗策略
J Natl Cancer Cent. 2022 Oct 20;2(4):243-262. doi: 10.1016/j.jncc.2022.10.002. eCollection 2022 Dec.
5
Radiation for hematologic malignancies: from cell killing to immune cell priming.血液系统恶性肿瘤的放疗:从细胞杀伤到免疫细胞激活
Front Oncol. 2023 Jun 13;13:1205836. doi: 10.3389/fonc.2023.1205836. eCollection 2023.
6
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma.肝细胞癌治疗中免疫抑制细胞的解读与逆转
J Liver Cancer. 2020 Mar;20(1):1-16. doi: 10.17998/jlc.20.1.1. Epub 2020 Mar 31.
7
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment.耗尽衰竭细胞:在肿瘤微环境中靶向调节性 T 细胞。
Front Immunol. 2022 Sep 30;13:940052. doi: 10.3389/fimmu.2022.940052. eCollection 2022.
8
Innate Lymphoid Cells: Role in Immune Regulation and Cancer.固有淋巴细胞:在免疫调节和癌症中的作用。
Cancers (Basel). 2022 Apr 21;14(9):2071. doi: 10.3390/cancers14092071.
9
Chemokine CCL17 Affects Local Immune Infiltration Characteristics and Early Prognosis Value of Lung Adenocarcinoma.趋化因子CCL17影响肺腺癌的局部免疫浸润特征及早期预后价值。
Front Cell Dev Biol. 2022 Mar 7;10:816927. doi: 10.3389/fcell.2022.816927. eCollection 2022.
10
FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.FOXP3/HAT1 轴通过诱导乳腺癌中 CCR4 的表达来控制肿瘤微环境中的 Treg 浸润。
Front Immunol. 2022 Feb 9;13:740588. doi: 10.3389/fimmu.2022.740588. eCollection 2022.